Epstein-barr virus antigens and related uses

TW202635711APending Publication Date: 2026-09-01VACCINE CO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142484
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-15
Filing Date
2025-10-31
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074572_001
    Figure TWG2TA001074572_001
  • Figure TWG2TA001074572_002
    Figure TWG2TA001074572_002
  • Figure TWG2TA001074572_003
    Figure TWG2TA001074572_003
Patent Text Reader

Abstract

Provided herein are engineered Epstein-Barr virus (EBV) polypeptides, polynucleotides encoding the same, related vectors and vaccine compositions, and related methods of making and using said compositions. The compositions disclosed herein may be useful for vaccination against EBV.
Need to check novelty before this filing date? Find Prior Art